Literature DB >> 11270596

Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants.

C Carrillo1, A Wigdorovitz, K Trono, M J Dus Santos, S Castañón, A M Sadir, R Ordas, J M Escribano, M V Borca.   

Abstract

We have recently communicated the oral and parental immunogenicity of the structural protein VP1 of foot and mouth disease virus (FMDV) expressed in different transgenic plants. Those results clearly indicated the necessity of increasing the expression of the foreign genes in the transgenic plant to avoid additional steps toward the purification and/or concentration of the antigen of interest. Here, we report the production of transgenic potatoes plants containing the VP1 gene cloned under the regulatory activity of either a single (pRok2) or a double (pRok3) copy of the S35 cauliflower mosaic virus (CaMV 35S) promoter, as a strategy for increasing the level of VP1 gene expression. The presence of the VP1 gene in the plants was confirmed by polymerase chain reaction (PCR) and its specific transcription activity was demonstrated by reverse transcriptase-polymerase chain reaction (RT-PCR). The results showed that, although the immunized animals presented a FMDV VP1 specific antibody response and protection against the experimental challenge, no significant differences were demonstrated in the immunizing activity of plant extracts obtained from the pRok2 or pRok3 transformed plants. These results confirm those previously obtained using other plant species allowing the possibility of using plants as antigen expression vectors, and demonstrated that at least in the potato system, the use of double CaMV 35S promoter does not cause a significant increase in the level of the VP1 expressed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270596     DOI: 10.1089/08828240151061383

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive.

Authors:  Dong Mei Wang; Jian Bo Zhu; Ming Peng; Peng Zhou
Journal:  Transgenic Res       Date:  2008-07-24       Impact factor: 2.788

Review 2.  Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.

Authors:  Natsumi Takeyama; Hiroshi Kiyono; Yoshikazu Yuki
Journal:  Ther Adv Vaccines       Date:  2015-09

3.  Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein.

Authors:  José M Martín-Alonso; Sonia Castañón; Pablo Alonso; Francisco Parra; Ricardo Ordás
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

Review 4.  Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals.

Authors:  Pit Sze Liew; Mohd Hair-Bejo
Journal:  Adv Virol       Date:  2015-08-13

5.  Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines.

Authors:  Ali Saeed; Muhammad Abubakar; Sehrish Kanwal; Memoona Arshad; Muhammad Ali; Rehan Sadiq Shaikh
Journal:  J Anim Sci Technol       Date:  2015-04-01

Review 6.  Plant cell factories and mucosal vaccines.

Authors:  Amanda M Walmsley; Charles J Arntzen
Journal:  Curr Opin Biotechnol       Date:  2003-04       Impact factor: 9.740

Review 7.  Plants as bioreactors for the production of vaccine antigens.

Authors:  Siddharth Tiwari; Praveen C Verma; Pradhyumna K Singh; Rakesh Tuli
Journal:  Biotechnol Adv       Date:  2009-04-06       Impact factor: 14.227

Review 8.  Plant production of veterinary vaccines and therapeutics.

Authors:  R W Hammond; L G Nemchinov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.